2026 Snapshot: Where Things Stand

As of early 2026, the Camp Lejeune litigation is one of the largest mass-tort proceedings in U.S. history. According to status reports filed in the Eastern District of North Carolina and the Department of Justice’s most recent public statements:

The Department of Justice announced on March 10, 2026 that it had approved 649 Elective Option offers in the preceding three weeks alone, totaling $175 million. Since January 20, 2025, DOJ has paid out more than $421 million; cumulative approved settlements since the Elective Option launched in 2023 stand at roughly $708 million across 2,531 offers. That is real money — but it is a fraction of the more than 400,000 administrative claims still pending with the Department of the Navy.

Several other developments define the current moment:

• The first bellwether trials — test cases that will help shape settlement values for everyone — are expected to begin in 2026. Most of the 25 bellwether cases did not settle during mediations held in summer 2025 and are proceeding toward trial.
• The federal courts ruled that Camp Lejeune plaintiffs are not entitled to jury trials under the Camp Lejeune Justice Act. The U.S. Supreme Court declined to hear an appeal in May 2025, leaving the bench-trial-only ruling in place for now. Legislation in Congress would restore the jury-trial right, but it has not yet passed.
• Court-appointed Settlement Masters are working on a broader global settlement matrix to address claims that fall outside the narrow Elective Option.

What Happened at Camp Lejeune

Marine Corps Base Camp Lejeune covers 250 square miles along the coast of Onslow County, North Carolina. Between August 1953 and December 1987, two of the base’s eight water-treatment plants drew from groundwater wells that had been contaminated by a combination of on-base activities — leaking underground storage tanks, industrial spills, and improper disposal of solvents — and an off-base dry cleaner, ABC One-Hour Cleaners, that mishandled chemicals near the Tarawa Terrace water-treatment plant.

The two contaminated systems were:

• Tarawa Terrace, which served family housing and the Knox trailer park. The primary contaminant was perchloroethylene (PCE) from the dry cleaner. The treatment main operated from 1952 until it was shut down in March 1987.
• Hadnot Point, which served barracks for unmarried personnel, the base hospital, administrative offices, schools, and an industrial area. Contaminants included trichloroethylene (TCE), benzene, vinyl chloride, and dichloroethylene (DCE).

A third water system — Holcomb Boulevard — supplied family housing. It was not directly contaminated, but Hadnot Point water was used to supplement Holcomb Boulevard during high-demand periods between 1972 and 1985, and continuously when the Holcomb plant was offline in early 1985. Many family members who drank, cooked with, and bathed in Holcomb Boulevard water were therefore also exposed.

The most contaminated wells were closed by February 1985. The contamination was not publicly disclosed until 1985, and the public health implications did not become widely known until the site was declared a federal Superfund site in 1989. The Agency for Toxic Substances and Disease Registry (ATSDR), part of the CDC, has been studying health outcomes for the affected population ever since.

The Chemicals in the Water

ATSDR has identified four primary contaminants of concern, all of them well-studied volatile organic compounds (VOCs):

• Trichloroethylene (TCE) — a metal-degreasing solvent. Maximum concentration measured at Hadnot Point reached 1,400 micrograms per liter, 280 times the current EPA Maximum Contaminant Level of 5 µg/L.
• Tetrachloroethylene / Perchloroethylene (PCE) — a dry-cleaning and metal-degreasing solvent. The maximum measured PCE level at Tarawa Terrace was 215 µg/L, 43 times the EPA limit.
• Benzene — a known human carcinogen used in fuels and chemical manufacturing. Detected in the Hadnot Point system from leaking fuel storage.
• Vinyl chloride (VC) — a degradation product of TCE and PCE in groundwater, classified as a human carcinogen.

Other VOCs detected at lower levels included trans-1,2-dichloroethylene (DCE), 1,1-dichloroethylene, methylene chloride, and toluene. Lead was also identified during a more recent (2005–2013) review of base drinking water.

ATSDR’s published assessment concluded that there is sufficient evidence linking these chemicals to a number of cancers, neurological disorders, birth defects, and other serious illnesses, drawing on both Camp Lejeune-specific health studies and broader epidemiologic literature involving similarly exposed populations.

The Camp Lejeune Justice Act of 2022

For decades, sovereign-immunity rules and a North Carolina statute of repose effectively shielded the federal government from Camp Lejeune lawsuits. That changed when President Joe Biden signed the Honoring Our PACT Act on August 10, 2022. Section 804 of that law — the Camp Lejeune Justice Act (CLJA) — created a narrow, two-year window for affected individuals to file claims for damages.

Key features of the CLJA:

• Cause of action. The Act allows anyone harmed by exposure to water at Camp Lejeune between August 1, 1953 and December 31, 1987 to sue the United States for damages.
• Burden of proof. The plaintiff must show that the contaminated water was at least “as likely as not” the cause of the injury — a lower bar than ordinary tort cases.
• Administrative-first rule. Before suing, the claimant must file an administrative claim with the Department of the Navy. A lawsuit can only be filed if the Navy denies the claim or fails to act within six months.
• Exclusive jurisdiction. All lawsuits must be filed in the U.S. District Court for the Eastern District of North Carolina.
• Filing deadline. The two-year window to file an administrative claim closed on August 10, 2024.
• Offset rule. Any award or settlement obtained through litigation may be offset by VA disability benefits, Medicare, or Medicaid payments related to the same exposure. Elective Option settlements are not subject to this offset.

Who Is Eligible to File a Claim

To bring a Camp Lejeune Justice Act claim, an individual must satisfy two basic requirements:

1. Presence. They (or, in the case of in-utero exposure, their mother) must have lived, worked, or otherwise been present at Camp Lejeune or Marine Corps Air Station New River for at least 30 days — consecutive or cumulative — between August 1, 1953 and December 31, 1987.
2. Injury. They must have a diagnosed medical condition that is at least “as likely as not” linked to exposure to the contaminated water.

Eligibility is broad. It is not limited to active-duty Marines. It includes:

• Active-duty service members from any branch stationed at the base
• Reservists and National Guard members called to duty there
• Civilian employees who worked on base
• Spouses, children, and other family members who lived in base housing
• Children exposed in utero, whose mothers lived or worked at Camp Lejeune for at least 30 days during the nine months before birth
• Estates and personal representatives of individuals who have since died — wrongful-death claims are permitted

One important note: the Elective Option uses a base-wide approach. So long as you were at Camp Lejeune for at least 30 days during the qualifying period, you are eligible — even if you cannot prove you lived in housing served by one of the contaminated systems. In litigation, however, the government may require evidence that you were exposed to one of the specifically contaminated systems.

Qualifying Medical Conditions

Claimants face three overlapping but distinct lists of conditions, depending on which benefit or claim they are pursuing.

The Elective Option’s Tier 1 and Tier 2

The Department of Justice’s Elective Option settlement framework recognizes nine “Qualifying Injuries” identified by ATSDR as having causal evidence at the “equipoise and above” level:

VA presumptive disability conditions (for VA benefits)

Separately, the Department of Veterans Affairs recognizes eight presumptive disability conditions, established by regulation effective March 14, 2017, that automatically link to Camp Lejeune service for purposes of VA disability compensation: adult leukemia, aplastic anemia and other myelodysplastic syndromes, bladder cancer, kidney cancer, liver cancer, multiple myeloma, non-Hodgkin’s lymphoma, and Parkinson’s disease.

VA healthcare-eligible conditions

The 2012 Caring for Camp Lejeune Families Act covers 15 conditions for purposes of VA medical care and family-member medical-cost reimbursement. The list includes the eight presumptive conditions above plus breast cancer, esophageal cancer, female infertility, hepatic steatosis, lung cancer, miscarriage, neurobehavioral effects, renal toxicity, and scleroderma.

Conditions outside the Elective Option

If your condition is not on the Tier 1 or Tier 2 list, your claim is not automatically without merit — it simply won’t qualify for the streamlined Elective Option. Many other illnesses linked to TCE, PCE, benzene, or vinyl chloride exposure (for example, breast cancer, lung cancer, esophageal cancer, certain birth defects, and several neurological conditions) can still support a claim, but the case will need to proceed through full litigation, where causation must be established with medical and scientific evidence.

The Elective Option Settlement Framework

Frustrated by slow administrative-claim processing and growing pressure from the federal court, the Department of Justice and the Department of the Navy announced the Elective Option (EO) on September 6, 2023. The EO is a voluntary, expedited settlement program designed to resolve a subset of Camp Lejeune Justice Act claims quickly, without litigation.

To qualify for an Elective Option offer, a claimant must:

1. Have a diagnosed Tier 1 or Tier 2 qualifying injury;
2. Have been at Camp Lejeune for at least 30 days between August 1, 1953 and December 31, 1987;
3. Have been diagnosed or treated for the qualifying injury before August 10, 2022; and
4. Have been diagnosed or first treated at least 2 years after first exposure and no more than 35 years after last exposure at Camp Lejeune.

That last requirement — the so-called “latency window” — has been controversial. It disqualifies many claimants whose illnesses appeared either too soon (within two years of exposure) or, far more commonly, more than 35 years after they left the base. Plaintiffs’ counsel has criticized the 35-year cap as scientifically unsupported, and ongoing discussions between the parties have focused on whether the window should be relaxed.

Estimates of how many administrative claims qualify for the Elective Option vary. Only about 12 percent of claimants are thought to meet the strict eligibility criteria — fewer than one in eight. Even among those, the Department of the Navy generally requires substantial documentation before issuing an offer.

Key features of the Elective Option

• Per-claimant, not per-injury. A claimant with multiple Qualifying Injuries receives compensation for only one — the one yielding the highest offer.
• Guaranteed payment. Once an offer is accepted and paperwork is completed, payment is supposed to follow within roughly 60 days.
• No VA offset. Accepting an EO offer does not reduce VA disability benefits, VA healthcare, or Medicare fee-for-service benefits, and VA will not assert a lien against the payment.
• Waiver of further claims. Accepting an EO offer waives the claimant’s right to additional litigation for that injury.
• Right to decline. Claimants who decline an EO offer keep their administrative claim and can later file a federal lawsuit.

Settlement Amounts in Detail

Under the Elective Option, payment is determined by a two-by-three “grid” that combines the tier of the injury with the duration of exposure.

An additional $100,000 is added if the qualifying injury resulted in death. The maximum payment under the Elective Option is therefore $550,000 (Tier 1, more than 5 years’ exposure, plus the death adder), and the minimum is $100,000.

Based on the Department of Justice’s most recent disclosures, the average approved Elective Option settlement is just under $300,000. As of mid-March 2026, total approved offers stood at approximately $708 million across 2,531 claimants.

Many plaintiffs’ attorneys describe the Elective Option amounts as below what these cases would likely be worth at trial, particularly for advanced cancers, terminal illnesses, or progressive diseases like Parkinson’s that involve decades of medical costs and lost earnings. The DOJ’s own pre-litigation statements estimated the total face value of submitted claims at over $335 trillion — a figure that underscores the gap between current EO amounts and what claimants believe their cases are worth.

Outside the Elective Option

For claims that don’t fit the EO — either because the injury isn’t on the Tier 1/Tier 2 list, or the diagnosis falls outside the latency window, or the claimant simply chooses to litigate — there is no fixed settlement schedule. Compensation in litigation will depend on the severity and progression of the illness, past and future medical expenses, lost income and earning capacity, pain and suffering, length and intensity of exposure, strength of medical causation evidence, and available offsets (VA, Medicare, Medicaid). Until bellwether trials produce verdicts, no one knows what a “trial-tested” Camp Lejeune case will pay.

How the Claim and Lawsuit Process Works

The Camp Lejeune Justice Act creates a two-step process: an administrative claim followed (if necessary) by a federal lawsuit.

Step 1 — Administrative claim with the Department of the Navy

Every claim must start with the Navy Judge Advocate General’s (JAG) Tort Claims Unit. Claimants submit a Standard Form 95 (Claim for Damage, Injury, or Death) along with supporting documentation, including proof of presence at Camp Lejeune (DD-214, military orders, base housing records, employment records), medical records establishing diagnosis and treatment, death certificates and a long-form medical cause-of-death statement for wrongful-death claims, and records establishing the date of first treatment or diagnosis.

The Navy reviews the claim. Under the Elective Option, claims with sufficient documentation and a Tier 1 or Tier 2 qualifying injury are forwarded for a settlement offer. Claimants generally have 60 days to accept or decline an EO offer.

Step 2 — Federal lawsuit

If the Navy denies the claim or fails to resolve it within six months, the claimant can file a lawsuit in the U.S. District Court for the Eastern District of North Carolina. Suit must be filed within 180 days of denial. All four federal judges in that district are hearing CLJA cases, and the litigation has been organized into Tracks based on disease type.

Step 3 — Litigation tracks

The court has divided early cases into two tracks for purposes of bellwether trials. Track 1 covers bladder cancer, kidney cancer, leukemia, non-Hodgkin’s lymphoma, and Parkinson’s disease — five plaintiffs per disease, 25 cases total. Track 2 covers prostate cancer, kidney disease, lung cancer, liver cancer, and breast cancer. Discovery and pretrial motions have been ongoing throughout 2025 and into 2026. Most non-bellwether cases are stayed while the test trials move forward.

Bellwether Trials and the Jury-Trial Ruling

Two interrelated developments shape what 2026 may hold for the Camp Lejeune litigation: the bellwether trials and the now-settled fight over jury rights.

The bellwether trials

Bellwether trials are test cases. Their verdicts are not directly binding on other claimants, but they create real-world data on how courts respond to the evidence — and they typically drive settlement values for the rest of the litigation. In Camp Lejeune, the court selected 25 Track 1 cases representing the five most-common qualifying diseases.

The parties completed mediation on those 25 cases in summer 2025; most did not settle and are proceeding toward trial. As of April 2026, no firm trial dates have been set. Several factors are slowing the schedule, including dozens of pending Daubert motions filed by the Department of Justice seeking to exclude plaintiffs’ scientific experts, disputes over the proper causation standard under the CLJA, disagreements over how to handle the federal government’s own ATSDR water-modeling data, and government motions on damages offsets for VA, Medicare, and Medicaid payments. On March 20, 2026, a federal judge struck the expert reports of DOJ expert Dr. Julie Goodman after finding her revisions went far beyond the minor corrections court rules permit — a significant win for plaintiffs.

Plaintiffs’ counsel has urged the court to set trial dates promptly, noting that many bellwether plaintiffs are elderly or in declining health. The Plaintiffs’ Leadership Group has specifically asked for kidney-cancer cases to be tried first, given that more than 23,000 administrative claims involve kidney cancer.

The jury-trial ruling

In a major and controversial ruling, the federal judges in the Eastern District of North Carolina held that Camp Lejeune Justice Act plaintiffs are not entitled to a jury trial. Plaintiffs sought immediate appellate review, but the effort failed: the interlocutory appeal was denied, and the U.S. Supreme Court declined to hear the case (McBrine v. United States) in May 2025. All Camp Lejeune cases will proceed as bench trials, with a single judge serving as fact-finder.

Many plaintiffs’ attorneys believe juries would award more, particularly for pain-and-suffering damages, and view the ruling as a setback to overall settlement leverage — though bench trials do offer some predictability, since judges tend to award damages in narrower, more consistent ranges.

Elective Option vs. Litigation: How to Decide

Claimants who receive an Elective Option offer face a real choice with no obviously right answer. The decision should be made in close consultation with an attorney, but the trade-offs are worth understanding.

The Elective Option is often the better choice when the claimant is older or in poor health and needs resources soon, the case fits cleanly within Tier 1 or Tier 2 criteria, the claimant wants to avoid the stress of litigation, or the claimant does not have substantial out-of-pocket medical expenses or future-care costs.

Litigation is more often considered when the claimant has multiple qualifying conditions, the illness is progressive or terminal with substantial future-care costs, the injury isn’t on the Tier 1/Tier 2 list, the diagnosis falls outside the 2–35-year latency window, or the claimant has strong supporting medical and exposure evidence.

Relationship With VA Benefits

VA benefits and CLJA compensation are governed by separate laws and operate in parallel. A few key points are essential to understand.

VA disability presumption. Since March 14, 2017, the VA has presumed service connection for eight conditions (adult leukemia, aplastic anemia/MDS, bladder cancer, kidney cancer, liver cancer, multiple myeloma, non-Hodgkin’s lymphoma, and Parkinson’s disease) for veterans, reservists, and National Guard members who served at Camp Lejeune for at least 30 days between 1953 and 1987. Family members are not eligible for VA disability compensation, though many are eligible for medical-cost reimbursement under the 2012 Caring for Camp Lejeune Families Act.

VA disability presumption is not automatic. A veteran must still file VA Form 21-526EZ and submit a current medical diagnosis and proof of qualifying service. Direct service connection is also possible for conditions not on the eight-disease presumptive list if the veteran provides medical evidence linking the condition to Camp Lejeune service.

EO does not affect VA benefits. Per the Department of Justice’s published guidance, accepting an Elective Option settlement does not reduce VA disability compensation, VA healthcare access, or Medicare fee-for-service benefits. Awards or settlements obtained outside the EO — through trial verdicts or non-EO settlements — may be reduced by VA disability benefits and Medicare/Medicaid payments related to the same exposure. The scope of allowable offsets is one of the live disputes in the litigation.

Filing a CLJA claim does not require waiving any VA benefit, and VA benefits do not automatically translate into a successful CLJA claim. The two should generally be pursued together.

Deadlines and Time Limits

For claimants who filed timely, several other deadlines remain important. A claimant cannot file a federal lawsuit until either the Navy formally denies the claim or six months have passed since the claim was filed without resolution. Once the claim is denied (or six months have elapsed), the claimant generally has 180 days to file in federal court. Offers under the Elective Option are typically open for 60 days from the date of issuance. VA claims based on Camp Lejeune presumptive conditions have no Camp Lejeune-specific filing deadline, though earlier filings yield earlier effective dates.

Family Members, Wrongful Death, and Survivors

Family members who lived in base housing at Camp Lejeune for at least 30 days during the qualifying period are eligible to file CLJA claims on the same terms as service members. This includes spouses, children, and individuals exposed in utero. Many of the most significant cases from Camp Lejeune involve children who were born or grew up on base and developed cancer or birth defects later in life.

Family members are not eligible for VA disability compensation, but may qualify for medical-cost reimbursement under the 2012 Caring for Camp Lejeune Families Act for any of the 15 covered conditions. They are also eligible for Elective Option compensation if their illness fits Tier 1 or Tier 2.

If the affected person has died — whether before or after filing a claim — a personal representative or estate may pursue a wrongful-death claim. The Elective Option adds $100,000 to the base settlement amount in death cases. Documentation requirements include a long-form death certificate with cause-of-death information or a treating physician’s signed letter establishing that the qualifying injury caused or contributed to death.

Plaintiffs who die during the litigation can have their claims continued by their estates. Plaintiffs’ attorneys have repeatedly urged the court to expedite trials precisely because so many claimants are elderly and in declining health.

Practical Tips for Claimants

Whether you have already filed and are waiting for a decision, or you have received an Elective Option offer, a few practical steps can protect your position.

1. Gather and preserve documents. Service records, base housing records, medical records, employment records, photographs, and any correspondence that establishes presence at Camp Lejeune are critical. Original or certified copies are preferred.
2. Keep your attorney informed of contact-information changes. Offers are time-limited. A missed deadline can permanently affect your case.
3. Pursue VA benefits separately. Even if you have a CLJA claim, file or update your VA claim. Benefits do not automatically transfer between systems.
4. Verify your attorney is qualified. Only attorneys admitted to the U.S. District Court for the Eastern District of North Carolina can litigate CLJA cases there. Many marketing firms refer cases to a small number of larger firms; ask directly who will handle your case.
5. Be cautious of unsolicited offers. The Camp Lejeune litigation has attracted aggressive marketing. Legitimate firms do not promise specific settlement amounts or guaranteed outcomes.
6. Don’t rush to accept a settlement. Discuss any offer carefully with your attorney. The Elective Option may be the right choice, but it may not be — the answer depends on your specific medical situation, financial needs, and case strength.
7. Watch for deadlines and court notices. Mass-tort proceedings generate significant paperwork. Read everything, and respond promptly.
8. Stay informed about settlement-matrix developments. A broader global settlement is being negotiated by court-appointed Settlement Masters. Its terms could materially affect what your claim is worth.

Pending Legislation to Watch

Several bills introduced in Congress would, if enacted, materially alter the Camp Lejeune litigation. As of April 2026, none has been signed into law, but each is worth monitoring.

The Ensuring Justice for Camp Lejeune Victims Act, introduced by Representative Richard Hudson (R-NC) in July 2025, would clarify the right to a jury trial under the CLJA. The Department of Justice has opposed it, arguing the changes “risk delaying resolution for the most-deserving claimants.” The Camp Lejeune Justice Corrections Act, introduced by Representatives Greg Murphy (R-NC) and Deborah Ross (D-NC), would streamline the claims process and address backlog issues created by concentrating all cases in a single federal district. A bipartisan bill introduced in October 2024 by Senators Thom Tillis (R-NC) and Richard Blumenthal (D-CT) would expand jurisdiction to allow CLJA suits in additional federal courts and clarify the right to jury trial.

If any of these passes, the practical effect for claimants could be significant: faster case resolution, more available judges, and potentially higher settlement values driven by the restored threat of jury verdicts.

Frequently Asked Questions

Sources and Further Reading

This article draws on primary government sources and reputable reporting. For the most current information, consult the original sources directly.

1. U.S. Department of Justice, Civil Division, “Camp Lejeune Justice Act Claims” — official Elective Option guidance and FAQ. justice.gov/civil/camp-lejeune-justice-act-claims
2. U.S. Department of Justice, Office of Public Affairs, press release, March 10, 2026, “The Department of Justice Approves Historic Number of Settlements to Camp Lejeune Victims and Families.”
3. U.S. Department of the Navy, “Public Guidance on Elective Option for Camp Lejeune Justice Act Claims” (updated September 15, 2023; FAQ updated January 21, 2025). navy.mil
4. Agency for Toxic Substances and Disease Registry (ATSDR), Camp Lejeune resource pages. atsdr.cdc.gov/camp-lejeune
5. U.S. Department of Veterans Affairs, “Camp Lejeune Health and Disability Benefits,” and 38 C.F.R. § 3.307(a)(7). publichealth.va.gov/exposures/camp-lejeune
6. Honoring Our PACT Act of 2022, Pub. L. No. 117-168, § 804 (the “Camp Lejeune Justice Act of 2022”).
7. U.S. District Court for the Eastern District of North Carolina, In re: Camp Lejeune Water Litigation, status reports and case-management orders (2023–2026).
8. McBrine v. United States, U.S. Supreme Court certiorari denied, May 2025 (jury-trial appeal).
9. WECT News, March 10, 2026, reporting on DOJ approval of $175M in Camp Lejeune settlements.